abacavir / dolutegravir / lamivudine Oral Tablet
RxNorm concept 1546886, clinical dose form (scdf).
- RxCUI
- 1546886
- Term type
- Clinical dose form (SCDF)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1546886 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
abacavir / dolutegravir / lamiVUDine Oral Tablet
Related concepts
- Oral Tablet (DF, has dose form)
- lamivudine (IN, has ingredient)
- abacavir (IN, has ingredient)
- dolutegravir (IN, has ingredient)
- abacavir / dolutegravir / lamivudine Oral Tablet [Triumeq] (SBDF, has tradename)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 1546886 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1546886 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1546886. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.